Skandinaviska Enskilda Banken AB (Publ) / MRK
Skandinaviska Enskilda Banken AB (Publ)’s Merck & Co Inc Position
Does Skandinaviska Enskilda Banken AB (Publ) own Merck & Co Inc (MRK)? Not currently — the last reported position was 1.83M shares worth $192M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$192M
Q4 2025
Shares
1.83M
% of Portfolio
+0.77%
Quarters Held
29
position exited
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 1.83M | $192M | +0.77% |
| Q3 2025 | 1.73M | $145M | +0.58% |
| Q2 2025 | 1.83M | $145M | +0.63% |
| Q1 2025 | 1.92M | $172M | +0.85% |
| Q4 2024 | 1.86M | $183M | +0.83% |
| Q3 2024 | 2.30M | $261M | +1.20% |
| Q2 2024 | 2.43M | $301M | +1.44% |
| Q1 2024 | 2.55M | $336M | +1.64% |
| Q4 2023 | 2.04M | $222M | +1.29% |
| Q3 2023 | 1.96M | $201,790 | +1.32% |
| Q2 2023 | 2.26M | $260,681 | +1.71% |
| Q1 2023 | 1.87M | $198,920 | +1.39% |
| Q4 2022 | 1.97M | $218,504 | +1.64% |
| Q3 2022 | 1.77M | $152M | +1.18% |
| Q2 2022 | 1.41M | $128M | +0.94% |
| Q1 2022 | 1.34M | $110M | +0.65% |
| Q4 2021 | 1.16M | $90M | +0.46% |
| Q3 2021 | 646.3K | $49M | +0.27% |
| Q2 2021 | 1.47M | $114M | +0.70% |
| Q1 2021 | 2.08M | $160M | +1.06% |
| Q4 2020 | 3.00M | $245M | +1.69% |
| Q3 2020 | 2.85M | $237M | +1.73% |
| Q2 2020 | 2.43M | $188M | +1.52% |
| Q1 2020 | 2.96M | $228M | +2.43% |
| Q4 2019 | 2.74M | $249M | +1.96% |
| Q3 2019 | 2.60M | $219M | +1.85% |
| Q2 2019 | 1.68M | $141M | +1.21% |
| Q1 2019 | 1.80M | $150M | +1.37% |
| Q4 2018 | 1.54M | $117M | +1.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of MRK.